Many newly approved cancer therapeutics offer limited clinical benefits yet are still prescribed to patients. A common-sense revolution in oncology would prioritize treatments that meaningfully improve survival and quality of life.
This is a preview of subscription content, log in via an institution to check access.
References
Gyawali, B. et al. ESMO Open 6, 100117 (2021).
Abola, M. V. & Prasad, V. JAMA Oncol. 2, 139–141 (2016).
Abola, M. V. & Prasad, V. Mayo Clin. Proc. 91, 1668–1670 (2016).
Del Paggio, J. C. et al. JAMA Oncol. 7, 728–734 (2021).
Sharma, S. et al. J. Natl. Compr. Canc. Netw. https://doi.org/10.6004/jnccn.2021.7016 (2020).
Del Paggio, J. C. et al. Lancet Oncol. 18, 887–894 (2017).
Del Paggio, J. C. et al. Ann. Oncol. 28, 157–162 (2017).
Gyawali, B. et al. Lancet Oncol. 19, 288–290 (2018).
Gyawali, B. et al. Nat. Cancer 1, 142–145 (2020).
Raphael, M. J. et al. Nat. Rev. Clin. Oncol. 17, 271–272 (2020).
Booth, C. M. et al. Nat. Rev. Clin. Oncol. 16, 312–325 (2019).
Gyawali, B. et al. Br. Med. J. 374, n1959 (2021).
Gyawali, B. et al. Am. Soc. Clin. Oncol. Educ. Book 39, 374–387 (2019).
Hoffmann, T. C. & Del Mar, C. JAMA Intern. Med. 177, 407–419 (2017).
Smith, T. J. & Hillner, B. E. N. Engl. J. Med. 364, 2060–2065 (2011).
Weeks, J. C. et al. N. Engl. J. Med. 367, 1616–1625 (2012).
Hoffmann, T. C. & Del Mar, C. JAMA Intern. Med. 175, 274–286 (2015).
Fundytus, A. et al. JAMA Oncol. 7, 1757–1758 (2021).
Schnipper, L. E. et al. J. Clin. Oncol. 30, 1715–1724 (2012).
Schnipper, L. E. et al. J. Clin. Oncol. 33, 2563–2577 (2015).
Cherny, N. I. et al. Ann. Oncol. 28, 2340–2366 (2017).
Acknowledgements
We acknowledge E. Eisenhauer (Queen’s University, Kingston, Canada) and I. Tannock (Princess Margaret Cancer Centre, Toronto, Canada) for helpful comments on an earlier draft of the manuscript. C.M.B. is supported as the Canada Research Chair in Population Cancer Care. B.G. receives salary support from the Ontario Institute for Cancer Research funded by the government of Ontario.
Author information
Authors and Affiliations
Contributions
B.G. and C.M.B. contributed equally to the manuscript, including its conception, writing and editing.
Corresponding author
Ethics declarations
Competing interests
B.G. has received consulting fees from Vivio Health.
Rights and permissions
About this article
Cite this article
Gyawali, B., Booth, C.M. Cancer treatments should benefit patients: a common-sense revolution in oncology. Nat Med 28, 617–620 (2022). https://doi.org/10.1038/s41591-021-01662-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-021-01662-6
- Springer Nature America, Inc.
This article is cited by
-
Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross‐sectional study
Journal of Foot and Ankle Research (2023)